Advertisement

Topics

Companies Related to "Allergic Rhinitis Epidemiology Forecast 2025 Report Updated 10102017" [Most Relevant Company Matches] RSS

06:55 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Allergic Rhinitis Epidemiology Forecast 2025 Report Updated 10102017" found in our extensive corporate database of over 50,000 company records.

Showing "Allergic Rhinitis Epidemiology Forecast 2025 Report Updated 10102017" Companies 1–25 of 451

Extremely Relevant

Cobalis

Although Cobalis’ current research is focused on studying the effects of cyanocobalamin (the active ingredient in PreHistin™) on the reduction of symptoms associated with seasonal and perennial allergic rhinitis, we plan to sponsor clinical trials into other immunoglobulin-E (IgE)-mediated allergic diseases to expand our product line. These supplemental indications include: :: Pediatric do...


Asthma, Allergy & Immunology Clinic

Allergic rhinitis or "hay fever." Symptoms of allergic rhinitis are sneezing, congestion, itching and dripping of the nose, and itchy, watery eyes. There are basically two types of allergic rhinitis: seasonal (for example, during fall, spring, or both) and perennial (year-round). Seasonal allergic rhinitis refers to allergies caused by pollen from trees, grasses, and/or weeds. Perennial allergic r...

Evolutec Group plc

Evolutec discovers and develops novel biopharmaceuticals for allergic, anti-inflammatory and auto-immune diseases. Evolutec has progressed its lead therapeutic molecule, rEV131, a novel histamine binding protein, from discovery to completion of initial Phase II clinical trials in allergic conjunctivitis, rhinitis and ocular inflammation. Positive preclinical data has also been generated in asthma ...


Relevant

Somnus Medical Technology

Somnus Medical Technologies was formed to address several large, underserved opportunities in the management of the upper airway. The company currently markets Somnoplasty® as a treatment for obstructive sleep apnea arising from obstruction at the base of the tongue, habitual snoring from enlarged soft palate and uvula and chronic nasal obstruction caused by the turbinates. Obstructive sleep apne...

Atopix Therapeutics Ltd

Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK, with an innovative approach to allergy. The company is developing a novel class of oral anti-allergic medicines, called CRTH2 antagonists, to treat atopic dermatitis, asthma and allergic rhinitis. Its lead candidate is currently being studied in a Phase 2 clinical trial for severe atop...

EvaluatePharm

EvaluatePharma® – helping you to analyse the past and future performance of the pharmaceutical and biotechnology business sector.EvaluatePharma® provides comprehensive coverage of more than 400 companies and over 11,000 products from early stage R&D through to Marketed and beyond, tracking the past and future performance of the pharma and biotech business sectors.Historic sales (since 1986), c...

Pollen.com

www.Pollen.com, a division of SDI, has been supplying important information to millions of people with allergic conditions for more than 10 years. With reliable, up-to-the-minute allergy forecasts that show upcoming local airborne allergen conditions, along with the weather forecast, Pollen.com prepares allergy sufferers for the day by offering all the ...

Topigen Pharmaceuticals Inc.

TOPIGEN is developing several new classes of drugs and is actively progressing two drug candidates in Phase II trials for COPD and asthma. These drugs are uniquely focused on inhibiting multiple inflammation targets underlying the chronic pulmonary diseases. TOPIGEN also has a number of discovery research programs focused on the identification of novel compounds for the treatment of COPD and aller...

HealthLeaders-InterStudy

Health Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly and covering 35 states plus the District of Columbia, each report provides a detailed look at:

BIOTECH Patent News

BIOTECH Patent News is a monthly printed publication that keeps you updated on the latest events in the world of patented biotechnology. This site provides updates on the latest headlines from BIOTECH Patent News, summaries of recently issued US patents, descriptions of biotechnology available for license, and recent commentary and reviews by biotechology legal professionals. BIOTECH Patent Report...

CellZome AG

Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by Kinobeads™, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome's emerging pipeline includes a small molecule Histamine H4 receptor antagonist, ...

Caro Research

Caro Research is an independent consulting firm specializing in pharmacoeconomics, epidemiology and technology assessment. Our staff, comprised of investigators in medicine, epidemiology, economics, psychology, biostatistics, informatics, and health care policy emphasizes solid research at the forefront of the field. In addition, we have established an extensive network of both academic and privat...

AllergyEats

AllergyEats, a free, user-friendly website, provides valuable peer-based feedback about how well (or poorly) restaurants accommodate the needs of food-allergic customers. The peer ratings and feedback allow food-allergic and gluten-intolerant diners to quickly and easily find restaurants that will accommodate their specific dietary requirements – and ...

Society for Healthcare Epidemiology of America

The Association for Professionals in Infection Control and Epidemiology (APIC)

Association for Professionals in Infection Control and Epidemiology (APIC)

Marinomed Biotechnologie GmbH

Marinomed is a biopharmaceutical company discovering and developing innovative anti-viral and immunological treatments. Marinomed develops therapies against respiratory diseases based on its innovative anti-viral respiratory technology platform mavirex. Safety and efficacy of the mavirex technology have already been proven in clinical trials. The huge potential of the technology is reflected by...

Medscape, LLC

Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.Most specialty sites are organized consistently so you'll know where to find your favorite features as you move from specialty to specialty. Ea...

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities. Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioT...

Biomonitoring Info

What: An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC). For information o...

BioTech Stock Report

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation....

Pharmacy Times and U.S. News & World Report

U.S. News & World Report is a multi-platform publisher of news and analysis, which includes the digital-only U.S. News Weekly magazine, www.usnews.com, and www.rankingsandreviews.com. Focusing on Health, Personal Finance, Education, Travel, Cars, and Public Service/Opinion, U.S. News has earned a reputation as the leading provider of service news an...

Probably Relevant

Clinical Trials & Epidemiology Research Unit

The Clinical Trials & Epidemiology Research Unit (CTERU) was established in November 1996 with National Medical Research Council (NMRC) funding to provide essential infrastructure to support not-for-profit public-sector research through the conduct of (multicentre) clinical trials, epidemiological and evidence-based medicine studies to established international standards. In particular, CTERU seek...

Apitope

Apitope International NV, based in Belgium and the UK, is a world-class drug developer of immunotherapies for the treatment of autoimmune and allergic diseases, including multiple sclerosis, factor VIII intolerance, uveitis and Graves’ disease. The Company has a patented discovery platform which enables selection of disease-modifying peptide therapies...

Tanox

In the 1980s, Tanox scientists discovered a novel approach for the treatment of allergic disease by reducing the levels of immunoglobulin E (IgE) in the blood. IgE is one of a class of antibodies that is responsible for causing allergic reactions. In June 2003, an anti-IgE therapy, Xolair® (Omalizumab) For Subcutaneous Use, received approval from the U.S. Food and Drug Administration for the trea...


More From BioPortfolio on "Allergic Rhinitis Epidemiology Forecast 2025 Report Updated 10102017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks